Tell Me, Forget Me Not By Hannah Neale

Alzheimer’s disease (AD) is a progressive and fatal form of dementia, frequently seen in the elderly altering their cognition, thought process and behavior. AD is reported in about half of patients that have a dementia diagnosis; one study states that about 10.3% of the population over 65 years is affected by dementia with an increase to almost 50% over the age of 8 (Beattie, 2002). Alzheimer’s disease is not a normal part of the aging process in humans, but rather found in a group of diseases that affect the brain leading to a decline in mental and physical control. AD when diagnosed has a very slow and gradual course, initially affecting the individual’s short term memory (Beattie, 2002). Alzheimer’s disease is the 6th leading cause of death, affecting more than five million people in the United States and is also one of the most common forms of dementia. Dementia can be defined as a disorder of progressive cognitive impairment severe enough to affect daily functions of an individual’s life (Fillit, et al., 2002).

Alzheimer’s disease is a progressive brain disease which slowly destroys thinking and memory skills. These changes are severe enough to interfere with day to day life. This irreversible disease is the most common cause of dementia amongst the elderly, with an appearance of first symptoms after age 60.

Throughout history there have been reports of decreased memory and mental deterioration that accompanied old age. Alzheimer’s disease (AD) was named after Dr. Alois Alzheimer who described the symptoms in a woman in Germany in the 1907 but it was not until the 1970’s that AD was considered to be a major disorder and AD continues to be a major health concern worldwide (Reger, 2002).

As per Lakhan (2017), Alzheimer's disease (AD) is a disorder dealing with neurodegeneration manifesting the cognitive and behavioral impairment that extensively affects the lives of the people who have the disease. It doesn't have a cure and deals with a long pre-clinical period as well as a progressive course. In hippocampus and some areas of

Alzheimer’s disease is a degenerative brain disease of unknown cause that is the most common form of dementia. Alzheimer’s usually starts in late middle age or in old age and results in progressive memory loss, impaired thinking, disorientation and changes in personality and mood. It is an irreversible, progressive disorder that slowly destroys memory and thinking skills which leads to the eventual inability to carry out the simplest tasks. Alzheimer’s disease is the most common cause of dementia among older adults.

Alzheimer’s disease (AD) is a form of dementia that causes problems with memory, thinking, and behavior. AD typically involves the development of a progressive neuropsychiatric disorder that is characterized by gradual memory impairment, loss of acquired skills and emotional disturbances (Lee, Y. J., Han, S. B., Nam, S. Y., Oh, K. W., & Hong, J. T.). Every 67 seconds an individual in the United States develops AD. AD is the sixth leading cause of death in the United States. There are 5.3 million Americans diagnosed with AD (Latest Alzheimer's Facts and Figures). AD is one of the few degenerative diseases that cannot be prevented, stopped, or cured (Latest Alzheimer's Facts and Figures). Post-mortem examination of the brain of AD patients usually

In drug therapy, studies show that cholinesterase blocker can reduce psychiatric symptoms in patients with Alzheimer 's disease. Moreover, Alzheimer 's disease could cause insomnia, irritability, visual illusion, delusions and other symptoms. The drug such as hypnotics, antipsychotic drugs, antiepileptic drugs, anti-depression drugs will have good effects to those symptoms. Furthermore, study shows that neuro protective agent Namenda can block glutamate for the destruction of brain cells. Therefore, drugs that slowing down the continuing loss of life skills are currently the main treatments of moderate and severe dementia.

Alzheimer’s disease (AD) is a progressive and fatal form of dementia, frequently seen in the elderly altering their cognition, thought process and behavior. AD is reported in about half of patients that have a dementia diagnosis; one study states that about 10.3% of the population over 65 years is affected by dementia with an increase to almost 50% over the age of 85. (Beattie, 2002) Alzheimer’s disease is not a normal part of the aging process in humans, but rather found in a group of diseases that affect the brain leading to a decline in mental and physical control. AD when diagnosed has a very slow and gradual course, initially affecting the individual’s short term memory. (Beattie, 2002)

“What is Alzheimer’s disease (AD)?” Alzheimer’s disease is the most common form of dementia that affects an individual’s memory, cognition, and behavior disturbances that ultimately diminishes their quality of life.1-2 Dementia is not a specific disease it is a general term for a variety of symptoms that affect memory and intellectual thinking that causes difficulty in our tasks of daily living.(5) The confusion between these two terms is extraordinary. It’s helpful to think of dementia as the symptom and to think of AD as the cause of that symptom. Although, there are many causes of dementia for the purpose of this paper, Alzheimer’s will be the only one discussed.

Alzheimer’s disease is a type of dementia that causes problems with memory, thinking and behavior. It is also a progressive disease with no cure. Alzheimer’s disease was first discovered by Dr. Alois Alzheimer in 1906. He noticed changes in brain tissue of a woman who died of an unusual mental illness. Although there are many types of dementias, Alzheimer's is the most common. It accounts for 60-80% of dementia causes. Aging is a normal process but Alzheimer’s is not a normal part of the aging process. Early onset Alzheimer’s affects 5% of patients diagnosed with Alzheimer’s and it appears between the ages of 40’s and 50’s. Alzheimer’s is the 6th leading cause of death in the United States. There are many symptoms that come along with Alzheimer’s

The experiment was conducted within a year, which involved one hundred and twenty patients within the ages of fifty and above. These participants showed signs of acquiring Alzheimer’s disease due to the fact that they experienced a minor condition of dementia. The experiment was led in a double blind manner where both the subjects and researchers do not know which type of treatment the participants received. The participants were divided into two groups, an experimental group and a control group. The experimental group received the capsule

The material this week was very informative. One thing I did not give much consideration to when evaluating the cost of AD was the loss of wages. This would be especially true in early onset disease. If an individual is diagnosed in their mid-50s to early 60s they are still working age. Since early onset progresses quickly continuation of work would be unlikely. Example if a physician get diagnosed with AD it is unlikely he will be able to continue working due to liability issues. The same could be true for the significant other in the relationship. Working hours or days worked may have to be reduced in order to be home during night time hours when wandering and confusion seem to be more prevalent. Something I did not know, but was very delighted

A great deal of knowledge was gained from completing this assignment. Prior to researching and reviewing the literature, little knowledge was known about AD. I found it interesting that much research has been conducted in recent years. AD has a tremendous effect on society. I was very intrigued to learn about the causes of AD. There are multiple theories and approaches to understanding the causes of the disease. As a social worker, it is disappointing to realize that psychosocial interventions are not effective for these clients. Following this assignment, further research is going to be conducted on non-pharmacological interventions. If the disease is caught in the early stage, other interventions may be of some benefit. Due to the nature

Medicines available for Alzheimer’s Disease (AD) do not reverse or stop its progression but they

For the time being, there is no cure for AD. Current management involves treatment for cognitive, non-cognitive and behavioural symptoms only. The aims of the treatment are to promote independence and alleviating behavioural, cognitive, non-cognitive and psychological symptoms. Those aims are made to improve AD patient’s quality of life and well-being, which in return can increase well-being of caregiver too. High cost spend because of CB will be reduce, rate of hospitalisation will be lessen and admission to NHP will be delayed.